peshkov And the hits just keep on comin’. Walgreens (NASDAQ:WBA) opened the year trading for $26 and change. But before earnings debuted last week, the stock was trading for a bit below $16 a share. Fast-forward a couple of days, and WBA now trades for less than $12, and has now plummeted 56% in 2024. If there is a bright side to this story, it is that the quarterly dividend now yields 8%-plus. Veteran investors may wonder if that represents a sucker yield or an opportunity to lock in a hefty source of ...

Walgreens Boots Alliance (WBA) is a retail drugstore chain that sells prescription and non-prescription drugs. The company also sells general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing, and candy.Analysts have taken a bearish stance on the company’s outlook, landing the stock into a Zacks Rank #5 (Strong Sell).Image Source: Zacks Investment ResearchIn addition, the company is in the Zacks Retail – Pharmacies and Drug Stores indust ...

Walgreens Boots Alliance is looking to reduce its investment in the doctor-staffed clinic operator ... [+] VillageMD after billions of dollars in losses and the need to focus on more profitable ventures to turn around the drugstore chain.VillageMDWalgreens Boots Alliance is looking to reduce its investment in the doctor-staffed clinic operator VillageMD after billions of dollars in losses and the need to focus on more profitable ventures to turn around the drugstore chain.Walgreens chief executive officer T ...

Walgreens Boots Alliance, Inc. (WBA) delivered adjusted earnings per share (EPS) of 63 cents in the third quarter of fiscal 2024, down 37% from the year-ago quarter’s figure (same at constant exchange rate or CER). The figure missed the Zacks Consensus Estimate by 5.97%.GAAP earnings for the third quarter of fiscal 2024 were 40 cents per share compared with the year-ago quarter’s earnings of 14 cents.Total SalesWalgreens Boots recorded total sales of $36.35 billion in the fiscal third quarter, up 2.6% year ...

The stock is now trading at levels last seen in 1998.Share prices of Walgreens Boots Alliance (WBA -0.78%) plunged following the June 27 release of its fiscal third-quarter earnings report, with the stock having one of its worst days on record. The stock price has now fallen more than 53% since the start of 2024.Let's look at Walgreens' most recent quarterly report, why the stock plummeted, and whether now is the time to buy.Reduced guidance, store closures, and new planFor its fiscal Q3 (ended in May), Wal ...

After falling a long way, the pharmacy stock is trading at a surprisingly low valuation.Shares of Walgreens Boots Alliance (WBA -0.78%) were hammered about 20% lower on June 27. Investors were responding to a lowered forward outlook, and it isn't the first time in recent memory that the company's given shareholders disappointing news.When the market closed on June 27, shares of Walgreens stock were down by 60.5% from a peak they set last summer. At its beaten-down price, the stock offers a huge 8.2% dividen ...

After years of a downtrend in their price, shares of Walgreens Boots Alliance Inc. NASDAQ: WBA have thrown in the towel this time. In a single day, the stock is down over 25% in a sign that can’t be taken in any other way than a ‘run’ message. However, some remain hopeful about the stock recovering, but that would be severely disconnected from current fundamentals.Walgreens Boots Alliance TodayWBAWalgreens Boots Alliance$12.10 -0.09 (-0.74%) 52-Week Range$11.68▼$31.32Dividend Yield8.27%Price Target$20.64Add ...

Walgreens pharmacyGetty ImagesWalgreens is one of the most celebrated names in the retail pharmacy space, boasting innovation and convenience for its customers. However, in its latest earnings report, the company announced a tough financial environment and outlook, citing “a worse-than-expected U.S. consumer environment.”Without a doubt, inflation has struck Americans at all levels—from the rise in costs of groceries and food to skyrocketing housing payments and insurance rates. Consumer sentiment towards t ...

PCE inflation matches expectations … the “haves” versus “have nots” dynamic playing out for consumers and the stock market … why it all points toward “trading”Is the “good news” good enough?This morning, the Fed’s favorite inflation gauge, the Personal Consumption Expenditures Price Index (PCE) came in according to expectations.Here’s CNBC:The core personal consumption expenditures price index increased just a seasonally adjusted 0.1% for the month and was up 2.6% from a year ago, the latter number down 0.2 ...

Core Viewpoint - Walgreens Boots Alliance, Inc. is facing significant challenges, including declining stock prices and operational difficulties, despite some recent improvements in quarterly results [1][3][10]. Financial Performance - In Q3 2024, Walgreens Boots Alliance reported sales of $36,351 million, reflecting a 2.6% year-over-year growth, and an operating income of $111 million, a turnaround from an operating loss of $477 million in Q3 2023 [3][4]. - Diluted earnings per share increased from $0.14 in Q3 2023 to $0.40 in Q3 2024, marking a 186% year-over-year growth [3]. - Free cash flow improved from a negative $444 million to a positive $334 million in the same quarter [3]. Segment Analysis - The U.S. Retail Pharmacy segment generated $28,503 million in sales with a 2.3% year-over-year growth, but adjusted operating income declined 47.9% to $501 million [4][5]. - The International segment saw sales increase to $5,727 million, a 2.8% growth, but adjusted operating income fell 15.9% to $175 million [5][6]. - The U.S. Healthcare segment reported a 7.6% year-over-year sales growth to $2,125 million, but still faced an operating loss of $220 million [6]. Impairment and Balance Sheet - A significant non-cash goodwill impairment charge of $12.4 billion was recognized due to a downward revision in the long-term forecast from VillageMD management [7]. - Goodwill on the balance sheet decreased from $28,187 million to $15,821 million, indicating a substantial write-off [7]. - The company has limited cash reserves of $703 million, raising concerns about liquidity, especially with $1,506 million in short-term debt and $7,407 million in long-term debt [7][8]. Dividend Policy - Walgreens Boots Alliance cut its dividend to $0.25 per share, a nearly 50% reduction, losing its status as a dividend aristocrat [9]. - The current annual dividend of $1.00 results in a yield of 6.3%, but further cuts may be necessary depending on cash generation in the upcoming quarters [9]. Future Outlook - Management has lowered the adjusted EPS guidance for fiscal 2024 to a range of $2.80 to $2.95, reflecting ongoing challenges in the retail pharmacy business and a difficult consumer environment [10][11]. - Despite some signs of hope, the overall sentiment remains cautious, with the company needing to manage its turnaround effectively to regain profitability [13].